Patients

HHV-6 has been associated with various clinical complications, including roseloa, chronic fatigue syndrome, multiple sclerosis, encephalitis, and drug hypersensitivity.  Although nearly everyone is infected with HHV-6 in childhood, only a small percentage experience reactivation of HHV-6 later in life.  Moreover, many of these reactivation events never cause symptoms in affected individuals.  However, evidence has shown that HHV-6 reactivation can occur at any time during the lifespan with resulting effects in a number of biological systems in the body.  We encourage you to explore the resources at right to learn more about testing, treating, and identifying HHV-6 primary infection and reactivation.